February 2022 - At the iCMLf Forum in December, we brought together a panel of leading experts and patient advocates to discuss the next big challenges and future directions in CML.

If you would like like to hear more about these key areas of research including; disease persistence in CML, treatment-free remission for all and TKI resistance in addition to BCR::ABL1 mutations – view the Forum videos on the iCMLf website.

We also take the opportunity to say a big THANK YOU to everyone who sent us the research questions that you believe need to be answered to help us move closer to a CML cure over the next 5-10 years.

Each year on the 15th of February, the world recognises International Childhood Cancer Day. A day that raises awareness about childhood cancer, and expresses support to those affected and their families, as well as recognising the need for more research and access to better care.

This year, the International CML Foundation is proud to share our part in providing access to up-to-date knowledge in paediatric CML practices, in hopes to thus create better care for children and young adults with CML around the world. So without further ado, we’re pleased to officially announce the launch of Phase II of the iCMLf Knowledge Centre and our first Module: Paediatric CML.

January 2023 - Please save the date for the first iCMLf Conversation of 2023. Professor Mhairi Copland from the University of Glasgow will be our CML expert on Wednesday, February 22^nd at 12 pm Central European Time.

During this live expert talk, we will focus on advanced phases of CML.
Professor Copland will share her expertise on the outcomes for blast phase CML and novel therapy options and will provide guidance on how to best treat your CML patients in advanced stages of CML.

There will be an interactive Q&A session at the end and all your questions, or cases are welcome for an open discussion.

Collage iCMLf Prizes winners 2022 Kopie January 2023 - We hope you had a wonderful start into the New Year. In 2023, we continue with our tradition to recognise and reward excellence in the management and research of CML with the iCMLf Prizes.

Over the past years, we have honoured 33 scientists, clinicians and patient advocates with the three specific prizes. It has now turned into an impressive gallery of ‘Giants in CML’ – people who played a major role in advancing our understanding of the biology of CML and to improving the management of CML throughout their career.

Who would you like to see awarded the iCMLf prizes this year?

You can nominate colleagues and mentors for the three prizes below:

As the year draws to a close we would like to express our appreciation for your continued interest, support and commitment to our work. 2022 has been a great success for the Foundation, with advancements in our CML research and expanding our ongoing commitment to the global CML community. Despite finding our way into a ‘new norm’ after the peak of the pandemic, together we rose to the challenges for one shared mission:

Improving the outcomes for people with CML globally

December 2022 - Our last iCMLf Conversation of 2022 will take place this coming Monday.

Don’t forget to join us and Professors Ravi Bhatia and Michael Mauro for the clinical and biological updates on CML presented during ASH. This is the perfect opportunity for those who were unable to attend the meeting or for those who would like to get a recap of the CML data presented.

Date: Monday, December 19^th at 2 pm Central European Time on Zoom.
Dial-in link for Zoom: https://us02web.zoom.us/j/81528835184

Read more about the program and other time zones…

Page 13 of 44

Copyright © 2023 All Rights Reserved. The iCMLf is registered as charity no. 1132984 in England and Wales
Registered Address: International CML Foundation - 20 Eversley Road - Bexhill-On-Sea, East Sussex, TN40 1HE - UK